UK’s MHRA approves molnupiravir as first oral antiviral to treat Covid-19
The approval was based on positive results from the Phase 3 MOVe-OUT trial and follows the MHRA and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Nov 21
The approval was based on positive results from the Phase 3 MOVe-OUT trial and follows the MHRA and…
01 Nov 21
The US regulator has indicated Pfizer-BioNTech Covid-19 vaccine, also called Comirnaty, in a two-dose regimen of 10µg doses…
01 Nov 21
Also known as a STAMP inhibitor, Scemblix is the first FDA-approved CML treatment that works by binding to…
28 Oct 21
Novartis’ filing was supported by the ELARA trial, which showed that treatment using Kymriah resulted in superior response…
27 Oct 21
The FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) reviewed the data, and voted 17 to 0,…
25 Oct 21
Susvimo, earlier known as Port Delivery System with ranibizumab, is said to be the first and only FDA-approved…
22 Oct 21
The EC approval was based on results from the Phase 3 CheckMate-649 trial, which showed positive outcomes for…
21 Oct 21
The US FDA has also authorised the use of heterologous booster dose of Covid-19 vaccines, in addition to…
20 Oct 21
Zuranolone is an oral, once-daily, two-week therapy intended to treat major depressive disorder (MDD) and postpartum depression (PPD)
20 Oct 21
Lenalidomide is a generic version of Celgene’s Revlimid, intended to treat multiple myeloma (MM), myelodysplastic syndromes (MDS), and…